Related Experiment Video
Updated: Aug 14, 2026

16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
Cardiac resynchronization therapy: overcoming ventricular dyssynchrony in dilated heart failure
1Cedars-Sinai Medical Center, Los Angeles, California 90048, USA. kerwinw@cshs.org
Cardiology in Review
|July 11, 2003
Summary
Cardiac resynchronization therapy (CRT) improves outcomes for patients with dilated heart failure and conduction delays. This review covers CRT
Area of Science:
- Cardiology
- Heart Failure Research
- Cardiac Electrophysiology
Background:
- Dilated heart failure (DHF) carries a poor prognosis despite optimal medical treatment.
- Intraventricular conduction delay, including bundle branch block, signifies advanced heart failure and worse outcomes.
- Certain patients with DHF and conduction delays can benefit from advanced pacing techniques.
Purpose of the Study:
- To review the pathophysiology of ventricular dyssynchrony in DHF.
- To provide an overview of pivotal clinical trials evaluating cardiac resynchronization therapy (CRT).
- To discuss practical aspects of achieving ventricular resynchronization, focusing on biventricular pacing.
Main Methods:
- Literature review and synthesis of existing research on ventricular dyssynchrony and CRT.
- Analysis of major clinical trials assessing the efficacy of CRT in heart failure patients.
- Discussion of technical considerations for implementing biventricular pacing.
Main Results:
- Ventricular dyssynchrony is a key mechanism contributing to DHF progression.
- Clinical trials demonstrate significant benefits of CRT in selected heart failure populations.
- Effective CRT implementation requires careful patient selection and pacing strategies.
Conclusions:
- CRT offers a valuable therapeutic option for DHF patients with intraventricular conduction delays.
- Understanding ventricular dyssynchrony is crucial for optimizing CRT outcomes.
- Biventricular pacing is the primary modality for achieving cardiac resynchronization.
More Related Videos
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

